- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Fund Finance
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- Innovation Protection
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Corporate and Securities Litigation
- E-Discovery
- Global Construction and Infrastructure Disputes
- Innovation Protection
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy Transition
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- Artificial Intelligence (AI) and Machine Learning
- Buy American
- Crisis Management
- Doing Business in Latin America
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
Events 184 results
Webinar
April 23, 2026
AI in EU Pharma: Navigating Efficiency, Innovation and Regulatory Challenges
Conference
April 8, 2026
Annual California Life Sciences Summit
Speaking Engagement
April 2, 2026
Christina Markus and Geneviève Michaux to Speak at two European Cell and Gene Therapy Research Consortia
Webinar
März 25, 2026
Using Science Offensively in Litigation: Strategies From Recent Trials in Hellhole Jurisdictions
Webinar
März 12, 2026
Key Revisions of the EU General Pharmaceutical Legislation
Conference
März 12, 2026
35th Annual King & Spalding Health Law & Policy Forum
Webinar
Februar 18, 2026
Is the NSA IDR Process Dead?
Speaking Engagement
Dezember 8, 2025
Ulf Grundmann to Speak at Frankfurt School of Finance and Management’s International Healthcare Management MBA program
Webinar
November 20, 2025
Pricing and Reimbursement in Europe
Webinar
November 19, 2025
Prescription for Trouble: FDA’s “Crackdown” on Drug Ads
Conference
November 13, 2025
Medical Device Forum
Conference
November 4, 2025
King & Spalding Pharmaceutical University 2025